Synergism of Caspofungin and Terbinafine Against Clinical and Environmental Isolates of Cryptococcus Neoformans

朱利平,翁心华,章强强,张永信

DOI: https://doi.org/10.3760/j.issn:1000-6680.2004.02.012

2004-01-01

Abstract:To evaluate the in vitro interactions of caspofungin and terbinafine against Cryptococcus neoformans.Methods 78 clinical and environmental isolates of Cryptococcus neoformans was tested by a modified National Committee for Clinical Laboratory Standards(NCCLS)microdilution assay,and the interactions were examined using a checkerboard design.Resuls Caspofungin MICs ranged from 0.25 μg/ml to 32 μg/ml,with a median(MIC at which 50% of the isolates are inhibited)of 32 μg/ml.Terbinafine MICs ranged from 2.0 μg/ml to 16 μg/ml,with a median of 8 μg/ml.A synergistic interaction was observed in 5%(4 of 78)of the isolates,and 42%(33 of 78)of the isolates yielded additive and 53%(41 of 78)of the isolates showed an indifferent interactions.Thus,the interaction of their combinations was synergisticto-additive for 47% isolates.Antagonism had not been observed.The geometric mean MIC of caspofungin dropped from 26.8 to 20.6 μg/ml(P＜ 0.0001),and that of terbinafine dropped from 7.9 to 1.3 μg/ml(P ＜ 0.0001)when tested in combination.While,the caspofungin MICs of the four isolates were 2 μg/ml,2 μg/ml,0.5 μg/ml and 0.25 μg/ml respectively.Conclusions In vitro synergistic drug sensitivity test indicated that the combined use of caspofungin-terbinafine resulted in better antifungal action against C.neoformans.